369 related articles for article (PubMed ID: 14754406)
21. Merkel cell carcinoma induces lymphatic microvessel formation.
Werchau S; Toberer F; Enk A; Dammann R; Helmbold P
J Am Acad Dermatol; 2012 Aug; 67(2):215-25. PubMed ID: 22050913
[TBL] [Abstract][Full Text] [Related]
22. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer].
Chen YN; Gu Y
Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632
[TBL] [Abstract][Full Text] [Related]
23. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
24. Targeting lymphangiogenesis to prevent tumour metastasis.
Achen MG; Mann GB; Stacker SA
Br J Cancer; 2006 May; 94(10):1355-60. PubMed ID: 16641900
[TBL] [Abstract][Full Text] [Related]
25. Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.
Yonemura Y; Endo Y; Tabata K; Kawamura T; Yun HY; Bandou E; Sasaki T; Miura M
Int J Clin Oncol; 2005 Oct; 10(5):318-27. PubMed ID: 16247658
[TBL] [Abstract][Full Text] [Related]
26. Role of lymphangiogenic factors in tumor metastasis.
He Y; Karpanen T; Alitalo K
Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763
[TBL] [Abstract][Full Text] [Related]
27. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.
Karnezis T; Shayan R; Caesar C; Roufail S; Harris NC; Ardipradja K; Zhang YF; Williams SP; Farnsworth RH; Chai MG; Rupasinghe TW; Tull DL; Baldwin ME; Sloan EK; Fox SB; Achen MG; Stacker SA
Cancer Cell; 2012 Feb; 21(2):181-95. PubMed ID: 22340592
[TBL] [Abstract][Full Text] [Related]
28. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
29. Development of Lymphatic Capillary Network Along the Alveolar Walls of Autopsied Human Lungs with Pneumonia.
Yamashita M; Niisato M; Hanasaka T; Iwama N; Takahashi T; Sugai T; Ono M; Yamauchi K
Lymphat Res Biol; 2016 Dec; 14(4):210-219. PubMed ID: 27617628
[TBL] [Abstract][Full Text] [Related]
30. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
31. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
32. Lymphangiogenesis Facilitates Initial Lymph Formation and Enhances the Dendritic Cell Mobilizing Chemokine CCL21 Without Affecting Migration.
Karlsen TV; Reikvam T; Tofteberg A; Nikpey E; Skogstrand T; Wagner M; Tenstad O; Wiig H
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2128-2135. PubMed ID: 28935759
[TBL] [Abstract][Full Text] [Related]
33. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
[TBL] [Abstract][Full Text] [Related]
34. [Lymphangiogenesis in cancerous tumours].
Bednarek W; Wertel I; Kotarski J
Ginekol Pol; 2008 Sep; 79(9):625-9. PubMed ID: 18939514
[TBL] [Abstract][Full Text] [Related]
35. Interaction of tumor cells and lymphatic vessels in cancer progression.
Alitalo A; Detmar M
Oncogene; 2012 Oct; 31(42):4499-508. PubMed ID: 22179834
[TBL] [Abstract][Full Text] [Related]
36. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
37. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
[TBL] [Abstract][Full Text] [Related]
38. Current strategies for modulating lymphangiogenesis signalling pathways in human disease.
Stacker SA; Hughes RA; Williams RA; Achen MG
Curr Med Chem; 2006; 13(7):783-92. PubMed ID: 16611067
[TBL] [Abstract][Full Text] [Related]
39. Tumor-induced lymphangiogenesis: a target for cancer therapy?
Thiele W; Sleeman JP
J Biotechnol; 2006 Jun; 124(1):224-41. PubMed ID: 16497404
[TBL] [Abstract][Full Text] [Related]
40. [Recent advances on lymphangiogenesis and lymphatic metastasis].
Liu FF; Lang RG; Fu L
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):267-70. PubMed ID: 17706122
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
